Merck KGaA MKKGY
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.22% | -1.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.22% | -1.70% | |||
| Cost of Revenue | 8.98% | -5.70% | |||
| Gross Profit | 2.69% | 1.20% | |||
| SG&A Expenses | 2.54% | -0.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 459.09% | 8.74% | |||
| Total Operating Expenses | 10.84% | -2.39% | |||
| Operating Income | -19.98% | 1.53% | |||
| Income Before Tax | -26.76% | 117.73% | |||
| Income Tax Expenses | -27.43% | 161.06% | |||
| Earnings from Continuing Operations | -26.56% | 107.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 57.24% | -86.94% | |||
| Net Income | -26.13% | 107.76% | |||
| EBIT | -19.98% | 1.53% | |||
| EBITDA | -12.49% | 9.11% | |||
| EPS Basic | -26.10% | 108.22% | |||
| Normalized Basic EPS | -26.09% | -21.64% | |||
| EPS Diluted | -26.10% | 108.22% | |||
| Normalized Diluted EPS | -26.09% | -21.64% | |||
| Average Basic Shares Outstanding | -0.04% | -0.23% | |||
| Average Diluted Shares Outstanding | -0.04% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 100.33% | -- | |||